Merck recycles a mutagenic drug and calls it a gamechanger for Covid recovery

[HennyPenny]

The drug EIDD-2801 which was dumped by its previous owners because it caused birth defects is being renamed
MK-4482 and being touted by Merck as an oral anti viral. Since drug manufacturers are protected by law now from liability of damage from pandemic counter measures, be careful of what you take: it may be something old dressed up as something new.


https://www.organicconsumers.org/blog/d ... -peril-one

Raymond Schinazi, an Emory University chemist who has extensively studied the active ingredient in EIDD-2801 but has no connection to DRIVE, notes that his former pharmaceutical company, Pharmasset, abandoned it in 2003 after discovering its mutagenic properties. Schinazi says the small chemical tweaks made to increase the ingredient’s bioavailability and transform it into EIDD-2801 are unlikely to change its mutagenicity. “Thank goodness someone is raising the red flag,” about EIDD-2801, Schinazi says. “You don’t develop a drug that’s mutagenic. Period.


https://www.sciencemag.org/news/2020/05 ... id-19-drug

“This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission,” says Richard Plemper, a professor at Georgia State University and researcher at the Institute for Biomedical Sciences. “MK-4482/EIDD-2801 could be game-changing.”


https://www.futurity.org/mk-4482-eidd-2 ... 2482452-2/

https://www.newsmax.com/finance/compani ... z6knmDdu7h